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Tetraploid cells generated by abnormal cell division are often arrested during the cell cycle or
cleared by apoptosis. Evasion of these defense mechanisms leads to genomic instability and
tumorigenesis. In this issue, Ganem et al. report that extra centrosome-induced activation of the
Hippo pathway kinase LATS2 is a key mechanism of tetraploidy-induced cell-cycle arrest.Tetraploidy (having four sets of chromo-
somes) can result from failed cell division.
For example, chromosome nondisjunc-
tion and telomere crisis can result in
cytokinesis failure, thus generating binu-
cleated cells. Alternatively, cells under
prolonged spindle assembly checkpoint
arrest can become tetraploid with a single
large nucleus due to mitotic slippage, a
slow progression through mitosis. Tetra-
ploid or aneuploid cells are commonly
found in cancer. It has been shown that
p53-inactive tetraploid, but not p53-
inactive diploid, mammary epithelial cells
produce malignant tumors in nude mice
(Fujiwara et al., 2005). Thus, tetraploidy
is proposed to be causal to tumorigen-
esis. The tumorigenic potential of tetra-
ploid cells could be due to the genomic
instability caused by chromosome mis-
segregation (Ganem et al., 2009). Tetra-
ploid cells are normally arrested in the
G1 phase of the cell cycle in a p53-depen-
dent manner, thus limiting the risk
of genomic instability, aneuploidy, and
tumorigenesis. However, the mechanism
of tetraploidy-induced G1 arrest is not
completely understood.
In this issue of Cell, Ganem et al. (2014)
identify essential genes specific for tetra-
ploidy-induced cell cycle arrest by RNAi
screening and gene expression profiling
(Figure 1). Importantly, the Hippo tumor
suppressor pathway kinase LATS2 spe-
cifically functions in tetraploidy-induced,
but not DNA damage-induced, G1 arrest.
LATS2 is activated in tetraploid cells, and
its knockdown induces binucleated cell
mitosis almost as potently as knockdown
of p53. LATS2 is reported to activate p53by inhibiting Mdm2 (Aylon et al., 2006),
and this phenomenon is confirmed in
the context of tetraploidy. In the Hippo
pathway, LATS2 phosphorylates the
transcription coactivator YAP to promote
YAP cytoplasmic retention and degrada-
tion (Yu and Guan, 2013). Interestingly,
expression of active YAP dramatically
increases the ploidy of hepatocytes
in vivo, suggesting that YAP may be an
effector downstream of LATS2 in ploidy
regulation.
Tetraploid cells are different from
diploid cells in many ways. For example,
tetraploid cells have double the amount
of DNA, a larger cell volume, and in most
cases, extra centrosomes. Although the
idea that there is a checkpoint directly
counting chromosome or centrosome
number is fascinating, this notion is not
supported by experimental evidence. In
addition, DNA damage or other off-target
effects of cytoskeleton poisons used to
induce tetraploidy could not be the major
reason of G1 arrest. Thus, the source of
the signal triggering tetraploidy-induced
cell-cycle arrest had not been pinpointed.
The study by Ganem et al. (2014) shows
that tetraploid cells have lower Rho
activity, which is at least partially due to
increased Rac activation in the presence
of excess microtubules nucleated by ex-
tra centrosomes. Restoring Rho activity
enables the cell to bypassG1 arrest. Inter-
estingly, Rho is also known to indirectly
but potently suppress LATS1/2 activity
in the Hippo pathway. Consistently,
enhanced cell-matrix adhesion, which
activates Rho, is reported to reduce G1
arrest of tetraploid cells. The currentCell 15study also demonstrates that lysophos-
phatidic acid stimulation, which is known
to activate Rho and inhibit LATS2 (Yu
and Guan, 2013), alleviates tetraploidy-
induced G1 arrest. Thus, it is reasonable
to speculate that Rho integrates various
upstream signals to control G1 arrest
of tetraploid cells, which may explain
the leakiness of the hypothesized ‘‘tetra-
ploidy checkpoint.’’ Previous reports
have demonstrated that LATS2 translo-
cates from the cytoplasm to the nucleus
following microtubule disruption, which
correlates with p53 activation (Aylon
et al., 2006).Whether LATS2 translocation
is involved in Rho-induced inhibition is an
interesting open question. It is of note
that, although naturally evolved prolifer-
ating tetraploid cells lose their extra cen-
trosomes, the accompanied inactivation
of LATS2 is not simply mediated by
reactivation of Rho but is instead tran-
scriptionally regulated. This would be an
important consideration when designing
strategy to target tetraploid cells.
This study, together with a previous
one, demonstrates the critical role
of LATS2 in both cytokinesis failure
and mitotic slippage-induced G1 arrest
(Figure 1). Importantly, LATS2 is also
involved in oncogene-induced cell-cycle
arrest. Decreased LATS2 expression
was observed in cells that evaded H-
RasV12-induced cell-cycle arrest (Aylon
et al., 2009). Thus, tetraploid cells and
oncogene-expressing cells adopt a
similar strategy to evade cell-cycle arrest.
In addition, knockdown of LATS2 also
leads to bypass of senescence such as
that induced by Rb (Tscho¨p et al., 2011).8, August 14, 2014 ª2014 Elsevier Inc. 695
Figure 1. LATS2 in Tetraploidy-Induced Cell-Cycle Arrest
Most tetraploid cells have extra centrosomes and abnormal cytoskeleton, which lead to genomic insta-
bility. On the other hand, tetraploid cells are prevented from erotic cell divisions by cell-cycle arrest, largely
due to p53 activation, although activation of growth factor signaling can bypass cell-cycle arrest in a
p53-independent manner. A model is proposed that extra centrosomes initiate G1 arrest via a Rac-
Rho-LATS2-YAP pathway. Activation of certain GPCR signaling inhibits LATS2 and enhances evasion of
cell-cycle arrest. LATS2 also promotes proper cytokinesis and inhibits centrosome overduplication, thus
inhibiting tetraploidy. The Hippo pathway is highlighted in blue.Therefore, an intriguing question is how
generally LATS2 activation is involved in
cell-cycle arrest induced by various in-
sults. It was recently found that the gain
of YAP activity is an important mechanism
during relapse of K-Ras-dependent can-
cers after Ras inhibition (Kapoor et al.,
2014; Shao et al., 2014). Therefore, YAP
activation may be a substitute for LATS2
inhibition in overriding growth arrest.
LATS2 and its homolog, LATS1, are
known to function in cytokinesis. Inactiva-
tion of LATS1 abrogates cytokinesis in
HeLa cells, and LATS1 knockout mouse
fibroblast (MEF) cells have an elevated
rate of multinucleation. LATS2 knockout
MEF cells have an increased failure
of cytokinesis, centrosome amplification,
polyploidy, and aneuploidy (McPherson
et al., 2004). However, caution should be
taken in interpreting these data because
the accumulation of multinucleated cells
could be due to either cytokinesis failure
or the bypass of cell-cycle arrest. In
budding and fission yeasts, the LATS ho-696 Cell 158, August 14, 2014 ª2014 Elseviemologs Dbf2p and Sid2p are central to
the mitotic-exit network and septation-
initiation network, respectively. Thus, the
function of LATS2 in later phases of
mitosis may be conserved to some extent
through evolution, although the mecha-
nisms are likely different.
The study by Pellman and colleagues
reveals a critical role of the Hippo
pathway, particularly LATS2 and YAP,
in tetraploidy-induced cell-cycle arrest.
Given the known function of the Hippo
pathway in regulating apoptosis, one
may speculate that LATS2 activation also
contributes to apoptotic elimination of
tetraploid cells that are acciden-
tally produced in normal tissues. How-
ever, some important questions remain.
For example, the underlying mechanism
of LATS2 inhibition by Rho remains
elusive. The mechanism of LATS2 in p53
and cell-cycle regulation is also not
completely understood. Current evidence
suggests that tetraploidy activates
LATS2, which then inhibits Mdm2. How-r Inc.ever, the mechanism of LATS2 in Mdm2
regulation is unclear. In addition, although
expression of active YAP breaches tetra-
ploidy-induced cell-cycle arrest, the role
of endogenous YAP in this process has
not been directly tested. Other effectors
downstream of LATS2 mediating tetra-
ploidy-induced G1 arrest possibly exist.
Nevertheless, this study suggests that
arresting the cell cycle of tetraploid
cells, and thus maintaining genomic sta-
bility, might be a new mechanism for the
tumor suppressor function of the Hippo
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